Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by Pandoraon Sep 20, 2023 6:30pm
467 Views
Post# 35646310

Another Patent Update

Another Patent Update
Hopefully I am not getting mixed up here. I am tracking 3 TLT patent applications. I sent notes out last week on two of them.

1)The Cannabinoid one getting Notice of Allowance status -- meaning the next stage will be payment of a fee.

2) The "Inactivation of Pathogen" one getting a rejection.

3) The third one "Sonodynamic Therapy ....." was given Notice of Allowance back on July 19, 2023.

The payment of fees for that Allowance on the third one has now been paid, meaning that in a short while we should get a Patent Number assigned and a Patent issued.

17/192,569 | T1081/20043:

SONODYNAMIC THERAPY USING SONODYNAMICALLY ACTIVATED COORDINATION COMPLEXES OF TRANSITION METALS AS SENSITIZING AGENTS

Public view
Application #

17/192,569

Confirmation #

5826

Attorney Docket #

T1081/20043

Patent #

-

Filing or 371 (c) date

03/04/2021

Status

Publications -- Issue Fee Payment Received 09/20/2023
 

 
 


 


<< Previous
Bullboard Posts
Next >>